Does Nutrisystem Have More Room to Run?

Mr. Market seems to like the business developments at weight-management services provider Nutrisystem, pushing its stock price up sharply over the past 12 months. Does the company still have some upside?

Jun 22, 2014 at 9:31AM

Weight-management services provider Nutrisystem (NASDAQ:NTRI) hasn't been a great long-term investment, as evidenced by its modest price appreciation over the past five years. The company's sales growth has been hurt over that time frame by rising competition in the diet business, a trend that has hurt the fortunes of other major players in the space, including Weight Watchers International (NYSE:WTW).

However, Nutrisystem surprised Mr. Market with a double-digit revenue increase, as well as slightly better than expected profitability, in its latest financial update. These data points led to a subsequent pop in its share price, continuing a rebound from its mid-2013 lows. So, after some good price action, does the company have more upside ahead?

What's the value?
Nutrisystem is one of the major players in the diet business, primarily selling portion-controlled meals, as well as shakes and snacks, through television and online distribution channels. Like its competitors, the company has benefited from a rise in the number of people who are overweight, which the World Health Organization estimates will encompass roughly 2.3 billion people worldwide by 2015. However, turning those potential customers into buyers of its products has been harder than it would seem at first glance, resulting in a downward trajectory for Nutrisystem's top line over the past few years.

Its latest fiscal year was a continuation of the trend for Nutrisystem, as evidenced by a 9.8% decline in revenues that was a function of lower overall customer volumes. On the upside, though, the company's strategic decision to reduce promotional product giveaways improved its average product pricing. In addition, the initiation of cost savings programs, including workforce reductions, cut Nutrisystem's corporate overhead, allowing it to return to operating profitability during the period.

Looking into the crystal ball
Of course, the question for investors is whether Nutrisystem can channel higher sales into profit growth, thereby creating a solid foundation for its stock price. Unfortunately, the data in that respect isn't looking great, judging by a double-digit fall in its adjusted operating profit during its latest fiscal quarter.

Also worrisome is the performance of competitors in the diet space, like Weight Watchers International, the world's largest provider of weight-loss services. Despite a major investment in its digital capabilities, the company has been hurt by a big drop-off in its meetings-based business, where attendance declined by a double-digit percentage in its latest fiscal year. Even Weight Watchers' online business, its focus of growth, saw momentum dissipate during the period, a trend that management blamed on the proliferation of free online activity trackers and diet apps. The net result for the company was a decline in operating profit, down 7.1%.

Likewise, weight-management services provider Medifast (NYSE:MED) has seen its top-line growth slow to a trickle lately, after enjoying a more than doubling of its sales from fiscal year 2009 to 2012. While the company's overall revenues were flat in FY 2013 versus the prior-year period, its weight centers segment had a relatively poor sales performance, down 6.4%, a negative trend that has caused management to seek franchisee partners for its company-owned stores. On the plus side, the strategic shift to a franchisee model has eliminated the related overhead, improving Medifast's operating profitability and providing greater cash flow to invest in product development, highlighted by the recent introduction of its new Flavors of Home line of replacement meals.

The bottom line
Mr. Market seems to like Nutrisystem's recent business developments, pushing the company's share price up more than 60% over the past 12 months. Indeed, Nutrisystem showed some sales momentum in its latest fiscal quarter, with revenues up 15.9%, something that has been absent over the past few years. That said, Nutrisystem still seems to be a work in process, given its marginal profitability, which is far below the operating margins of competitors like Weight Watchers International and Medifast.  As such, the company is an intriguing turnaround story, but prudent investors are probably better off watching the action from the sidelines.

Try as you might, you can't stay on the sidelines of this battle
You know cable's going away. But do you know how to profit? Right now, media companies are battling tooth and nail for a spot in your living room, as there's $2.2 trillion out there to be had for the victor. Currently, cable grabs a big piece of that. But that won't last. And when cable falters, three companies are poised to benefit. Click here for their names. Hint: They're not Netflix, Google, and Apple. 


Robert Hanley owns shares of Medifast. The Motley Fool owns shares of Weight Watchers International. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information